Notice: This company has been marked as potentially delisted and may not be actively trading. Intec Pharma (NTEC) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Indaptus Therapeutics reports Q3 EPS (32c) vs. (47c) last yearNovember 13, 2024 | markets.businessinsider.comFinTechOn 2024: FinTech Associations from 14 Asian Economies Sign MOU to Enhance Collaborations in Anti-FraudNovember 6, 2024 | finance.yahoo.comX4 Pharmaceuticals, Inc. (XFOR)September 21, 2024 | finance.yahoo.comINDP Indaptus Therapeutics, Inc.August 23, 2024 | seekingalpha.comBuy Rating Affirmed for Indaptus Therapeutics Amid Positive Decoy20 Clinical DevelopmentsAugust 13, 2024 | markets.businessinsider.comWill Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs InMay 14, 2024 | msn.comBuy Rating Affirmed for Indaptus Therapeutics Amid Promising Decoy20 Clinical AdvancementsMay 10, 2024 | markets.businessinsider.comBuy Rating Affirmed for Indaptus Therapeutics Amid Positive Clinical and Financial OutlookMarch 15, 2024 | markets.businessinsider.comBuy Rating Affirmed on Indaptus Therapeutics as Decoy20 Advances in Phase 1 with Promising DevelopmentsMarch 7, 2024 | markets.businessinsider.comStocks to Watch Today: RVNL,Glenmark Pharma, PB Fintech,Sula Vineyards and moreFebruary 18, 2024 | msn.comChhattisgarh education minister calls for expansion of central schools in the stateFebruary 2, 2024 | msn.comH.C. Wainwright Sticks to Its Buy Rating for Indaptus Therapeutics (INDP)August 15, 2023 | markets.businessinsider.comNGENF - NervGen Pharma Corp.June 16, 2023 | finance.yahoo.com10-Q: INDAPTUS THERAPEUTICS, INC.May 12, 2023 | marketwatch.comFibromyalgia Treatment Market Research | 2023-2030May 10, 2023 | marketwatch.comEarly Pregnancy Test Kit Market May Set Epic Growth Story Major Players – Abbott, Church & Dwight, SPD Swiss Precision Diagnostics GmbHMay 9, 2023 | marketwatch.comFibromyalgia Treatment Market Share, Size, Financial Summaries Analysis from 2023 to 2028May 4, 2023 | marketwatch.comFibromyalgia Treatment Market Share by 2031April 28, 2023 | marketwatch.comIntec Pharma Ltd (5NU.SG)April 24, 2023 | ca.finance.yahoo.comFibromyalgia Treatment Market Size, Share, Outlook and Forecast to 2031March 30, 2023 | marketwatch.comMaxim Group Reaffirms Their Buy Rating on Indaptus Therapeutics (INDP)March 18, 2023 | markets.businessinsider.comFibromyalgia Treatment Market Forecast: An Analysis of Industry Trends for 2023-2028March 2, 2023 | marketwatch.comGlobal Parkinson’s Disease Treatment Market Opportunities, Business Statistics Research Report 2030 By VMReportsFebruary 19, 2023 | marketwatch.comFibromyalgia Treatment Market Size 2023 With Over-All Dominated, Share Of Everywhere, Ease Of Access Of SolutionsFebruary 15, 2023 | marketwatch.comSyphilis Rapid Test Kit Market : Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2028January 30, 2023 | marketwatch.comFibromyalgia Treatment Market Industry Updates, New Opportunities, Major Strategies, And Forecast 2028January 23, 2023 | marketwatch.comWith 1.7% CAGR, Fibromyalgia Treatment Market 2023 Is Flourishing Around the World by 2028 | 116 Pages ReportDecember 29, 2022 | marketwatch.comFibromyalgia Treatment Market (New Report) to Witness A Pronounce Growth During 2023-2028 | 116 Pages ReportDecember 21, 2022 | marketwatch.comFibromyalgia Treatment Market Size in 2022 with Latest Report of 100 Pages & Business Forecast up to 2028 by Value Chain Analysis | No of Pages 100October 17, 2022 | marketwatch.comFibromyalgia Treatment Market Size and Share 2022 Analysis Report by Industry Trends, Drivers, Applications, Sale and Forecast to 2028August 28, 2022 | marketwatch.comWorld Holdings Co Ltd (2429)July 5, 2022 | investing.comBeroe Inc.: Beroe partners with Mintec to power its intelligence offering with market-leading commodity price dataJune 4, 2022 | finanznachrichten.deEXEL INDUSTRIES :2020-2021 Full-year results: Significant improvement in margins combined with a sharp reduction in debtDecember 18, 2021 | finanznachrichten.deDataiku Increases Commitment to the Japanese Market to Accelerate Everyday AI in JapanDecember 10, 2021 | yahoo.comGenetron earnings preview: what Wall Street is expectingDecember 1, 2021 | markets.businessinsider.comHere's what Wall Street expects from Cipher Pharmaceuticals's earningsNovember 12, 2021 | markets.businessinsider.comIntec Closes Merger with Decoy BiosystemsAugust 3, 2021 | finance.yahoo.comIntec Announces Expected Closing Date of Decoy MergerAugust 3, 2021 | finance.yahoo.comIntec Parent Shares Up 60%July 29, 2021 | marketwatch.comBRIEF-Intec Announces $30 Mln Private Placement Ahead Of Decoy MergerJuly 26, 2021 | msn.comIntec Pharma in $30 Million Private PlacementJuly 26, 2021 | marketwatch.comIntec Announces $30 Million Private Placement Ahead of Decoy MergerJuly 26, 2021 | finance.yahoo.comIntec Pharma Ltd. Ordinary Shares (NTEC)July 25, 2021 | nasdaq.com Get Intec Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for NTEC and its competitors with MarketBeat's FREE daily newsletter. Email Address I've got news for you… (Ad)Today, I’m doing something I thought I’d never do… Especially since I’m not normally a “swing for the fences” type of trader. But I’ve been quietly testing a new type of trade for a while now… And the returns are too good not to share with you. Take a look… I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the week watch this FREE briefing with me and expert trader Graham Lindman NTEC Media Mentions By Week NTEC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NTEC News Sentiment▼0.000.50▲Average Medical News Sentiment NTEC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NTEC Articles This Week▼00▲NTEC Articles Average Week Get Intec Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for NTEC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LEXX News CLNN News LTRN News ACST News PMN News OCUP News KALA News RNXT News CTXR News BIVI News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NTEC) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intec Pharma Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Intec Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
